Another biomarker used to predict PE is A-Disintegrin and Metalloprotease-12 (ADAM-12) decreased levels, in association with PAPP-A, correlate with the severity of IUGR (220), though findings are inconsistent for ADAM-12 association with PE and related disorders (221). This evidence concerns the gene ADAM12 and fetal growth restriction.